Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications

Principal investigator

Jay Achar
Purpose of study
Purpose of study

Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications.

Study status

  • Concept
  • Protocol & ERB
  • Implementation
  • Completion
  • Archived

Study timeline

Documents

No documents uploaded

Publications

  • Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications
    Swaminathan, A. "–" International Union Against Tuberculosis and Lung Disease "(2016)"
  • Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications
    Swaminathan, A. "–" International Union Against Tuberculosis and Lung Disease "(2016)"
Previous study
Next study